TrialJournal of patient-reported outcomes2023

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.

Wytske Fokkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.